Hints and tips:
...But within a year of the US Food and Drug Administration’s 2021 approval of the weight-loss drugs known as GLP-1 agonists, the threat of them breaking WW’s business model became clear....
...The antitrust challenge may force big pharma groups to rethink “pure play” business models. The Lex team is interested in hearing more from readers. Is the FTC right to challenge pharma deals?...
...I have freedom,” said Weiss, who was one of more than 1,700 participants in the late-stage trial of a drug called donanemab....
...Sinéad O’Sullivan is a senior researcher at Harvard Business School’s Institute for Strategy and Competitiveness....
...’s DCVax-L brain cancer drug....
...A January Forbes article named SBF as one of the group’s (then) billionaire backers....
...“This drug creates mutations in the virus but if you don’t kill the virus then some could get out,” the former Harvard professor said....
...Apple has attempted to make some inroads, for example partnering with Johnson & Johnson, the pharmaceutical group, to study how its watch can reduce the risk of stroke....
...Israel may even bring back the “green pass”, which allowed greater freedom for vaccinated people....
...deals with western pharmaceutical groups....
...and placebo groups....
...cost of drugs in the US....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...Pfizer has previously said it could receive emergency approval for the vaccine from the EMA’s US counterpart, the Food and Drug Administration, this month....
...Aaron Kesselheim, a professor at Harvard Medical School, believes the FDA needs to invest more in monitoring drugs after they have approved them....
...Beyond these three biotechs, Crispr could end up transforming the entire pharmaceutical industry....
...Their concentrated ownership of industries such as airlines and pharmaceuticals may push up travel and drug prices, some academics argue....
...Both Republicans and Democrats are trying to pressure the pharmaceutical industry to lower drug costs....
...He has been implacable in his assault on Brexiters, even likening cheerleaders of the cause in the European Research Group to Nazis. Two days after the vote, he tweeted: “Wake up....
...Some analysts expect the Celgene deal to push other large pharmaceutical companies to hunt for more acquisitions to bolster their cancer drug pipelines....
...She worked as a janitorial supervisor at C&W client Lonza, a Swiss pharmaceuticals group, which has a production facility in Portsmouth, New Hampshire....
...Shoshana Zuboff is the Charles Edward Wilson Professor Emerita at Harvard Business School....
...Beijing last year scrapped the requirement that foreign groups rerun medical trials in China to launch drugs already approved in their home market, and has increased its drug-approval staff eightfold since...
...But a more precise understanding of biology has led pharmaceutical companies to focus research and development efforts on treatments for rarer diseases, often aimed at small sub groups with a particular...
...For one, shares in Menlo Therapeutics, a pharmaceutical company making treatments for itchy skin and coughs, are down 53 per cent from their offer price after its drug serlopitant underperformed in one of...
International Edition